Literature DB >> 17192546

Targeted therapy for metastatic breast cancer.

Hyman B Muss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17192546     DOI： 10.1056/NEJMe068260

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.

Authors:  Laura M Shelton; Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

Review 2.  Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancer.

Authors:  Patricia Gomez; Mario E Lacouture
Journal:  Oncologist       Date:  2011-10-20

3.  The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.

Authors:  Robert Calaluce; Matthew M Gubin; J Wade Davis; Joseph D Magee; Jing Chen; Yuki Kuwano; Myriam Gorospe; Ulus Atasoy
Journal:  BMC Cancer       Date:  2010-04-06       Impact factor: 4.430

4.  Bacteria peptidoglycan promoted breast cancer cell invasiveness and adhesiveness by targeting toll-like receptor 2 in the cancer cells.

Authors:  Wenjie Xie; Yafang Huang; Wenling Xie; Aimin Guo; Wei Wu
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

5.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

6.  Outcomes of palliative weekly low-dose gemcitabine-Cisplatin chemotherapy in anthracycline- and taxane- pretreated metastatic breast cancer patients.

Authors:  Jung Sun Kim; In Hae Park; Keun Seok Lee; Jungsil Ro
Journal:  J Breast Cancer       Date:  2014-12-26       Impact factor: 3.588

7.  Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.

Authors:  Weilong Zhong; Shuang Chen; Yuan Qin; Heng Zhang; Hongzhi Wang; Jing Meng; Longcong Huai; Qiang Zhang; Tingting Yin; Yueyang Lei; Jingxia Han; Lingfei He; Bo Sun; Huijuan Liu; Yanrong Liu; Honggang Zhou; Tao Sun; Cheng Yang
Journal:  Oncotarget       Date:  2017-08-24

Review 8.  Lost in Translation: The Gap in Scientific Advancements and Clinical Application.

Authors:  Joseph S Fernandez-Moure
Journal:  Front Bioeng Biotechnol       Date:  2016-06-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.